Please enable JavaScript to continue using this application.

Compare $IDYA vs $LEGN | Chartloom

Compare

$IDYA vs $LEGN

IDEAYA Biosciences Inc · Legend Biotech Corp

IDYA

IDEAYA Biosciences Inc

LEGN

Legend Biotech Corp

Compare $IDYA vs $LEGN

Comparing IDEAYA Biosciences Inc and Legend Biotech Corp

IDYAIDEAYA Biosciences Inc

LEGNLegend Biotech Corp

IDYAIDEAYA Biosciences Inc

Market cap

$3.43B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

59.38x

Rev growth (TTM)

3244.7%

YTD performance

6.7%

52W performance

34.5%

FCF yield

-3.3%

LEGNLegend Biotech Corp

Market cap

$3.62B

P/E (TTM)

—

Forward P/E (NTM)

25.42x

Forward P/S (NTM)

2.17x

Rev growth (TTM)

59.6%

YTD performance

-13.4%

52W performance

-42.2%

FCF yield

-3.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IDYA

LEGN

Detailed metrics comparison

IDYA

IDEAYA Biosciences Inc

LEGN

Legend Biotech Corp

Market Cap

IDYA$3.43B

LEGN$3.62B

Enterprise Value

IDYA$3.16B

LEGN$3.23B

Price

IDYA$36.11

LEGN$18.62

P/E Ratio

IDYAN/A

LEGNN/A

P/S Ratio

IDYA14.66x

LEGN2.85x

EV/Sales

IDYA13.50x

LEGN2.54x

EV/EBITDA

IDYA0.00x

LEGN0.00x

P/B Ratio

IDYA3.01x

LEGN3.04x

P/FCF Ratio

IDYAN/A

LEGNN/A

EV/FCF

IDYA-27.76x

LEGN-26.50x

PEG Ratio

IDYAN/A

LEGNN/A

Forward P/E (NTM)

IDYAN/A

LEGN25.42x

Forward P/S (NTM)

IDYA59.38x

LEGN2.17x

Revenue (TTM)

IDYA$234M

LEGN$1.27B

Revenue Growth (YoY)

IDYA3244.7%

LEGN59.6%

Forward Rev Growth

IDYA218.2%

LEGN25.0%

Gross Margin (TTM)

IDYA0.0%

LEGN56.6%

Operating Margin (TTM)

IDYA0.0%

LEGN0.0%

EBITDA Margin (TTM)

IDYA-91.5%

LEGN-0.8%

Net Margin (TTM)

IDYA-74.8%

LEGN-7.2%

FCF Margin (TTM)

IDYA-48.6%

LEGN-9.6%

Net Income (TTM)

IDYA$-175M

LEGN$-92M

FCF (TTM)

IDYA$-114M

LEGN$-122M

EPS (TTM)

IDYA-$1.90

LEGN-$0.47

ROE (TTM)

IDYA-1647.0%

LEGN-870.0%

ROA (TTM)

IDYA-1511.0%

LEGN-539.0%

ROIC (TTM)

IDYA-1647.0%

LEGN-643.0%

Cash

IDYA$273M

LEGN$673M

Debt

IDYA$0

LEGN$278M

Net Cash/Debt

IDYA$273M

LEGN$395M

Current Ratio (TTM)

IDYA10.45x

LEGN3.04x

Quick Ratio (TTM)

IDYA10.21x

LEGN2.89x

Debt/Equity (TTM)

IDYA0.00x

LEGN0.23x

Debt/Assets (TTM)

IDYA0.0%

LEGN0.0%

Interest Coverage (TTM)

IDYAN/A

LEGNN/A

Net Debt/EBITDA (TTM)

IDYA0.00x

LEGN0.00x

Beta

IDYA0.04

LEGN0.57

52W Performance

IDYA34.5%

LEGN-42.2%

YTD Performance

IDYA6.7%

LEGN-13.4%

% from 52W High

IDYA-15.4%

LEGN-50.3%

% from 52W Low

IDYA38.6%

LEGN14.7%

Asset Turnover (TTM)

IDYA0.20x

LEGN0.75x

FCF Yield (TTM)

IDYA-3.3%

LEGN-3.4%

Earnings Yield (TTM)

IDYA-5.1%

LEGN-2.5%

Dividend Yield (TTM)

IDYAN/A

LEGNN/A

Rule of 40

IDYA3,196.0

LEGN50.0

EV/GP/RG

IDYAN/A

LEGN0.13

Ticker research

View IDYA research View LEGN research

Metric	IDYA IDEAYA Biosciences Inc	LEGN Legend Biotech Corp
Market & Valuation
Market Cap	$3.43B	$3.62B
Enterprise Value	$3.16B	$3.23B
Price	$36.11	$18.62
P/E Ratio	N/A	N/A
P/S Ratio	14.66x	2.85x
EV/Sales	13.50x	2.54x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.01x	3.04x
P/FCF Ratio	N/A	N/A
EV/FCF	-27.76x	-26.50x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	25.42x
Forward P/S (NTM)	59.38x	2.17x
Revenue & Growth
Revenue (TTM)	$234M	$1.27B
Revenue Growth (YoY)	3244.7%	59.6%
Forward Rev Growth	218.2%	25.0%
Profitability
Gross Margin (TTM)	0.0%	56.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-91.5%	-0.8%
Net Margin (TTM)	-74.8%	-7.2%
FCF Margin (TTM)	-48.6%	-9.6%
Net Income (TTM)	$-175M	$-92M
FCF (TTM)	$-114M	$-122M
EPS (TTM)	-$1.90	-$0.47
ROE (TTM)	-1647.0%	-870.0%
ROA (TTM)	-1511.0%	-539.0%
ROIC (TTM)	-1647.0%	-643.0%
Financial Health
Cash	$273M	$673M
Debt	$0	$278M
Net Cash/Debt	$273M	$395M
Current Ratio (TTM)	10.45x	3.04x
Quick Ratio (TTM)	10.21x	2.89x
Debt/Equity (TTM)	0.00x	0.23x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.04	0.57
52W Performance	34.5%	-42.2%
YTD Performance	6.7%	-13.4%
% from 52W High	-15.4%	-50.3%
% from 52W Low	38.6%	14.7%
Efficiency & Yields
Asset Turnover (TTM)	0.20x	0.75x
FCF Yield (TTM)	-3.3%	-3.4%
Earnings Yield (TTM)	-5.1%	-2.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	3,196.0	50.0
EV/GP/RG	N/A	0.13
Ticker research	View IDYA research	View LEGN research

Valuation

P/S Ratio

LEGN

2.85x

IDYA

14.66x

EV/FCF

IDYA

-27.76x

LEGN

-26.50x

Growth & revenue

Revenue Growth TTM

IDYA

3244.7%

LEGN

59.6%

Forward Revenue Growth

IDYA

218.2%

LEGN

25.0%

Profitability & performance

Gross Margin

LEGN

56.6%

IDYA

0.0%

ROE

LEGN

-870.0%

IDYA

-1647.0%

FCF Yield %

IDYA

-3.3%

LEGN

-3.4%

52-Week Performance

IDYA

34.5%

LEGN

-42.2%

Detailed metrics comparison

IDYA

IDEAYA Biosciences Inc

LEGN

Legend Biotech Corp

Market Cap

IDYA$3.43B

LEGN$3.62B

Enterprise Value

IDYA$3.16B

LEGN$3.23B

Price

IDYA$36.11

LEGN$18.62

P/E Ratio

IDYAN/A

LEGNN/A

P/S Ratio

IDYA14.66x

LEGN2.85x

EV/Sales

IDYA13.50x

LEGN2.54x

EV/EBITDA

IDYA0.00x

LEGN0.00x

P/B Ratio

IDYA3.01x

LEGN3.04x

P/FCF Ratio

IDYAN/A

LEGNN/A

EV/FCF

IDYA-27.76x

LEGN-26.50x

PEG Ratio

IDYAN/A

LEGNN/A

Forward P/E (NTM)

IDYAN/A

LEGN25.42x

Forward P/S (NTM)

IDYA59.38x

LEGN2.17x

Revenue (TTM)

IDYA$234M

LEGN$1.27B

Revenue Growth (YoY)

IDYA3244.7%

LEGN59.6%

Forward Rev Growth

IDYA218.2%

LEGN25.0%

Gross Margin (TTM)

IDYA0.0%

LEGN56.6%

Operating Margin (TTM)

IDYA0.0%

LEGN0.0%

EBITDA Margin (TTM)

IDYA-91.5%

LEGN-0.8%

Net Margin (TTM)

IDYA-74.8%

LEGN-7.2%

FCF Margin (TTM)

IDYA-48.6%

LEGN-9.6%

Net Income (TTM)

IDYA$-175M

LEGN$-92M

FCF (TTM)

IDYA$-114M

LEGN$-122M

EPS (TTM)

IDYA-$1.90

LEGN-$0.47

ROE (TTM)

IDYA-1647.0%

LEGN-870.0%

ROA (TTM)

IDYA-1511.0%

LEGN-539.0%

ROIC (TTM)

IDYA-1647.0%

LEGN-643.0%

Cash

IDYA$273M

LEGN$673M

Debt

IDYA$0

LEGN$278M

Net Cash/Debt

IDYA$273M

LEGN$395M

Current Ratio (TTM)

IDYA10.45x

LEGN3.04x

Quick Ratio (TTM)

IDYA10.21x

LEGN2.89x

Debt/Equity (TTM)

IDYA0.00x

LEGN0.23x

Debt/Assets (TTM)

IDYA0.0%

LEGN0.0%

Interest Coverage (TTM)

IDYAN/A

LEGNN/A

Net Debt/EBITDA (TTM)

IDYA0.00x

LEGN0.00x

Beta

IDYA0.04

LEGN0.57

52W Performance

IDYA34.5%

LEGN-42.2%

YTD Performance

IDYA6.7%

LEGN-13.4%

% from 52W High

IDYA-15.4%

LEGN-50.3%

% from 52W Low

IDYA38.6%

LEGN14.7%

Asset Turnover (TTM)

IDYA0.20x

LEGN0.75x

FCF Yield (TTM)

IDYA-3.3%

LEGN-3.4%

Earnings Yield (TTM)

IDYA-5.1%

LEGN-2.5%

Dividend Yield (TTM)

IDYAN/A

LEGNN/A

Rule of 40

IDYA3,196.0

LEGN50.0

EV/GP/RG

IDYAN/A

LEGN0.13

Ticker research

View IDYA research View LEGN research

Metric	IDYA IDEAYA Biosciences Inc	LEGN Legend Biotech Corp
Market & Valuation
Market Cap	$3.43B	$3.62B
Enterprise Value	$3.16B	$3.23B
Price	$36.11	$18.62
P/E Ratio	N/A	N/A
P/S Ratio	14.66x	2.85x
EV/Sales	13.50x	2.54x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.01x	3.04x
P/FCF Ratio	N/A	N/A
EV/FCF	-27.76x	-26.50x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	25.42x
Forward P/S (NTM)	59.38x	2.17x
Revenue & Growth
Revenue (TTM)	$234M	$1.27B
Revenue Growth (YoY)	3244.7%	59.6%
Forward Rev Growth	218.2%	25.0%
Profitability
Gross Margin (TTM)	0.0%	56.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-91.5%	-0.8%
Net Margin (TTM)	-74.8%	-7.2%
FCF Margin (TTM)	-48.6%	-9.6%
Net Income (TTM)	$-175M	$-92M
FCF (TTM)	$-114M	$-122M
EPS (TTM)	-$1.90	-$0.47
ROE (TTM)	-1647.0%	-870.0%
ROA (TTM)	-1511.0%	-539.0%
ROIC (TTM)	-1647.0%	-643.0%
Financial Health
Cash	$273M	$673M
Debt	$0	$278M
Net Cash/Debt	$273M	$395M
Current Ratio (TTM)	10.45x	3.04x
Quick Ratio (TTM)	10.21x	2.89x
Debt/Equity (TTM)	0.00x	0.23x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.04	0.57
52W Performance	34.5%	-42.2%
YTD Performance	6.7%	-13.4%
% from 52W High	-15.4%	-50.3%
% from 52W Low	38.6%	14.7%
Efficiency & Yields
Asset Turnover (TTM)	0.20x	0.75x
FCF Yield (TTM)	-3.3%	-3.4%
Earnings Yield (TTM)	-5.1%	-2.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	3,196.0	50.0
EV/GP/RG	N/A	0.13
Ticker research	View IDYA research	View LEGN research